The role of FGF signaling in early epithelial dierentiation was investigated in ES (embryonic stem) cell derived embryoid bodies. A dominant negative ®broblast growth factor receptor (FGFR) mutation was created by stably introducing into ES cells an Fgfr2 cDNA, truncated in its enzymatic domains. These cells failed to dierentiate into cystic embryoid bodies. No epithelial dierentiation and cavitation morphogenesis could be observed, in the mutant, although its rate of cell proliferation remained unchanged. This phenotype was associated with a signi®cant decrease in the activation of Akt/PKB and PLCg-1, as compared to the wild type, while the activation of MAPK/Erk was less aected. Requirement for PI 3-kinase signaling in embryoid body dierentiation was demonstrated by speci®c inhibitors. Akt/PKB activation was abrogated by wortmannin in short-term experiments. In long-term cultures Ly294002 inhibited the dierentiation of ES cells into embryoid bodies. Our data demonstrate that for early epithelial dierentiation FGF signaling is required through the PI 3-kinase-Akt/ PKB pathway.
Introduction
Growth factor signaling by receptor tyrosine kinases induces cell proliferation and dierentiation. A leading role is attributed to the MAPK/ERK pathway, in insect (Gabay et al., 1997) and vertebrate development (Northrop et al., 1995; Umbhauer et al., 1995) . Another signaling pathway, that leads through phosphatidyl-inositol 3-kinase (PI 3-kinase) and Akt/PKB, is also induced by the same receptors. Second messengers of the PI 3-kinase pathway, the phosphoinositide lipids of the plasma membrane, are involved in multiple cellular functions (Rameh and Cantley, 1999) , such as dynamic changes in the actin cytoskeleton (Wennstrom et al., 1994; Rodriguez-Viciana et al., 1997) , integrin signaling (King et al., 1997) and the support of cell survival. More recently it has been shown that the anti apoptotic role of this signaling pathway centers on, Akt/PKB, a serine threonine kinase (for review, Datta et al., 1999) .
Rearrangement of the actin cytoskeleton, cell motility and regulation of apoptosis are important for epithelial dierentiation, early embryonic development and cancer. Here we used cultures of ES cell derived embryoid bodies as a model system for early epithelial dierentiation (Bagutti et al., 1996) and embryogenesis (Coucouvanis and Martin, 1995) . Embryoid bodies are formed by ES cells, when cultured in conditions that favor self-aggregation, rather than adhesion to the culture dish. In these cultures, aggregates of ES cells develop into two epithelial layers, the outer polar endoderm and the internal pseudostrati®ed ectoderm, that are separated by a basement membrane and surround a central cavity formed by apoptosis. The external polar epithelium is similar to the visceral endoderm and the internal columnar layer to the embryonic ectoderm or epiblast, while the central cavity represents the proamniotic canal of the eggcylinder stage mouse embryo. Besides morphological similarities the gene expression patterns of the early embryos and embryoid bodies are also similar (McDonald and Heath, 1994; Coucouvanis and Martin, 1995; Bagutti et al., 1996; Barbacci et al., 1999 and references within) .
To study the role of FGF signaling, a dominant negative FGF receptor mutation was prepared. Overexpression of FGFR cDNA, truncated in the cytoplasmic kinase domains, inhibits signaling. Because dierent FGFR isotypes form heterodimers, the truncated receptor can inhibit multiple isotypes expressed in the same cell Ueno et al., 1991) . This multiple eect was the basis to choose a dominant negative mutation for this study. Our reasons for this choice were, that we suspected that multiple FGFR are active in early embryos and embryoid bodies and that ES cells carrying homozygous mutations of early acting FGFR isotypes, such as FGFR1 (Deng et al., 1994) and FGFR2 (Arman et al., 1999, and unpublished) form normal embryoid bodies. Here we report that all four FGFR are expressed in the embryoid body and that FGF signaling, through Akt/PKB, is required for their dierentiation.
Results

Embryoid bodies express all four FGFR
Transcripts of all four FGFR were reported in dierentiating ES cell derivatives (McDonald and Heath, 1994) and early mouse embryos . To investigate FGFR expression in the embryoid body cultures used in this project, immune-precipitation and in situ hybridization were performed. Our results support previous conclusions. Semi-thin sections of non-radioactive in situ hybridization revealed Fgfr1 and Fgfr2 transcripts in the inner columnar ectoderm (Figure 1a,b) , whereas Fgfr3 and 4 transcription was restricted to the visceral endoderm of the embryoid body (Figure 1c,d ). Weak signals of Fgfr1 ( Figure 1a ) and Fgfr2 could be detected also in undierentiated embryoid bodies, whereas the other two isotypes were detected only in the established visceral endoderm.
Dominant negative FGFR mutation abrogates embryoid body differentiation
Truncated Fgfr2 cDNA was expressed in a mammalian expression vector controlled by elongation factor Ef-1a (Mizushima and Nagata, 1990) , that was introduced into ROSA11 ES cells (Friedrich and Soriano, 1991) together with a Hygromycin resistance gene (te Riele et al., 1990) . Hygromycin resistant clones were further selected by RNA blot hybridization for the overexpression of truncated Fgfr2 mRNA. The truncated mRNA was easily detectable as an approximately 2.2 kb band (Figure 1e ), whereas the wild type message, detected by RT ± PCR, could not be detected (after the same exposure) in the Northern blot. Six dominant negative mutant ES cell clones, that gave similar results, were used in the study.
Wild type embryoid bodies showed visceral endoderm dierentiation by the third day of culture. This was recognized by the appearance of a sheet of vacuolated cells surrounding the embryoid body. At this stage the appearance of a second cell layer, the columnar ectoderm and incipient cavitation was also detectable (Figure 2a) . Mutant ES cells formed stem cell aggregates, but in these embryoid bodies no visceral endoderm developed, except in a small minority, where it appeared signi®cantly later than in the wild type. In addition, no columnar ectoderm and central cavity formed, and the mutant embryoid bodies remained stem cell aggregates (Figure 2b ) till the end of the culture period (6 ± 10 days), when around 80% of the wild type displayed cavitation. As control, ES cells containing empty vector that did not express the truncated Fgfr2 cDNA, displayed normal embryoid body dierentiation (not shown).
To further characterize this loss of function mutation, bio-chemical markers of endoderm dierentiation were studied. The synthesis of a-fetoprotein, and the transcription of HNF4 and Evx1 were investigated. Afetoprotein is a speci®c product of the mature visceral endoderm (Hogan et al., 1994) , whereas HNF4 (Duncan et al., 1997) and Evx1 (Spyropoulos and Capecchi, 1994) are transcriptional regulators, active during its early stages of dierentiation. Signi®cant inhibition of all three markers emphasized that endoderm dierentiation is defective in the dominant negative mutant (Figure 2c ± e and Figure 3a, b) . Embryoid bodies expressing truncated Fgfr2 cDNA also failed to cavitate and failed to express markers produced by derivatives of the epiblast-like ectoderm layer. During later stages of the culture (day 6 ± 10), in correspondence with gastrulation, the embryoid body produces hemopoietic precursors (Keller, 1995) . Preliminary studies revealed no, or little transcription of embryonic globin, Flk1 and stem cell factor in the mutant embryoid body.
Our cytological and biochemical data collectively suggest that FGF signaling is required for embryoid body dierentiation. Inhibition of growth factor receptor signaling in general and FGFR signaling in particular, may result in defective mitogenicity that in turn could abrogate dierentiation. To exclude this possibility, we compared the proliferation of wild type and mutant ES cells and embryoid bodies. Since ES cells are sensitive to serum starvation, proliferation experiments were performed in the serum containing ES cell medium.
Thymidine uptake of both wild type and mutant ES cells rose quickly to a plateau and then declined, suggesting a burst of proliferation followed by equilibrium at a saturation density (Figure 3c ). In embryoid body cultures thymidine uptake decreased with dierentiation, and after 3 days, both in the wild type and in the mutant stabilized at a lower level ( Figure 3c , right-hand panel). Lack of dierence of cell proliferation in dierentiated wild type and undierentiated mutant embryoid bodies was somewhat surprising. This nevertheless can be explained. While dierentiated wild type embryoid bodies undergo apoptotic cavitation, in the mutant as it reaches a certain size, growth and expansion slows down and necrotic foci develop (Coucouvanis and Martin, 1995) .
Another factor to be considered is that in presence of serum derived endogenous growth factors, cell proliferation in the FGFR-defective mutant could be the function of PDGF and other non-FGF growth factors. Since growth factors have a certain cell speci®city, one could assume that in absence of FGF signaling, the remaining growth factor activity would stimulate the proliferation of speci®c cells. This however is less than likely in our case, where the mutant embryoid body consists of homogenous undierentiated cells. We therefore conclude that, in this system, the dominant negative FGF receptor mutation aects dierentiation rather than mitogenicity.
Defective FGF signaling abrogates Akt/PKB and PLCg1 activation
Next we investigated the eect of the dominant negative FGFR mutation on MAPK/Erk and PI 3-kinase activation. To this end antibodies speci®c for activated MAPK/ERK, or against activated Akt/PKB were used in Western analysis, whereas PLCg-1 was analysed by immune-precipitation. Kinase activity was induced by a brief FGF1 and heparin pulse before lysis. To one aliquot wortmannin was also added to test the involvement of PI 3-kinase ( Figure 4) .
In wild type embryoid cultures the total level of MAPK/ERK p42 and p44 were slightly elevated as compared to the mutant (Figure 4a ). Using an antibody speci®c for activated MAPK/Erk, considerable degree of activation was observed in both cultures. In two out of three experiments MAPK activation in the wild type slightly surpassed that in the mutant (Table 1) , but in general MAPK/Erk activation did not seem to play a central role in this system.
In contrast to MAPK/Erk activation, Akt/PKB was activated 4 ± 10-fold more in wild type than in mutant embryoid body cultures ( Figure 4b and Table 1 ). As expected, Akt/PKB activation was strongly inhibited by the PI 3-kinase inhibitor wortmannin (and by Ly294002, not shown), which at the concentration used here, had no eect on MAPK activation (Figure 4a ). The kinetics of Akt/PKB activation was also studied. For this end the cultures were treated with vanadate, to inhibit phosphotase activity. This revealed that dierential Akt/PKB activation reaches its maximum at the third to fourth day of culture, following the kinetics of ES cell dierentiation, whereas the mutant displayed low values throughout the culture period (not shown).
Activation of PI 3-kinase is connected, through its lipid second messengers, to the activation of PLCg-1 (Bae et al., 1998; Falasca et al., 1998) and to the common auto phosphorylation site, Y766 of FGFR1 (Cross et al., 2000) . To investigate the role of PLCg-1 in embryoid body dierentiation, mutant and wild type cultures were activated by heparin and FGF1, with or without the PI 3-kinase inhibitor, wortmannin. The cells were lysed and PLCg-1 was immune-precipitated and subjected to Western blotting with anti phosphotyrosine. A dierentially activated phosphoprotein of 180 kD was detected in the wild type, but not in the mutant (Figure 4c, upper right panel) . A small amount of phosphoprotein corresponding to PLCg-1 (150 kD) was also detectable in these experiments. We believe that the high molecular weight phosphoprotein is complexed with weakly phosphorylated PLCg-1. The reason for the weak phosphorylation of PLCg-1 could be dephosphorylation by internal phosphatases (James et al., 1996) and indeed in the presence of vanadate, a phosphatase inhibitor, PLCg-1 phosphorylation was more readily detectable (not shown).
To identify the 180 kD phosphoprotein associated with PLCg-1, the lysates were reacted with anti FGFR1. The same 180 kD peptide was detected in the wild type, but not in the mutant, as with anti phosphotyrosine (Figure 4c, upper left panel) . This band may represent a highly glycosylated variant of FGFR1 with three Ig-like loops (Jaye et al., 1992) (second right-hand panel of Figure 3c ). The data demonstrate that the dominant negative FGFR mutation abrogates the activation of both FGFR1 and PLCg-1. Similar interactions between FGFR1 and PLCg-1 have been demonstrated previously (Mohammadi et al., 1991; Huang et al., 1995; Cross et al., 2000) .
Interestingly, activation of PLCg-1 was inhibited by wortmannin (Figure 4c ), although wortmannin speci®-cally reacts with the p85 moiety of PI 3-kinase, but not with PLCg-1 (Ui et al., 1995) . It has been demonstrated before, that PtdIns(4,5)-bis phosphate, phosphorylated at the 3' position by PI 3-kinase binds the PH domain of PLCg-1 and targets it to the cell membrane, where it binds FGFR1 (Bae et al., 1998; Falasca et al., 1998) . A feedback of PtdIns(4,5)-bisphosphate then could activate PI 3-kinase.
In a recent report Cross et al. (2000) described how phospholipase and PI 3-kinase activation is dependent on Tyr766 of FGFR1, and that while Tyr766 was not required for cell proliferation it was required for FGF mediated cytoskeletal reorganization. Although this is similar to our observations, since more than one FGFR is involved in embryoid body dierentiation, it will be important to know whether other FGFR isotypes also activate PLCg1 and PI 3-kinase through Tyr766. It is relevant to this point that targeted mutagenesis of Tyr766 of FGFR1 caused only late homeotic defects (Partanen et al., 1998) .
PI 3-kinase is required for normal embryoid body differentiation
The above data present evidence for the involvement of FGF signaling in embryoid body dierentiation through PI 3-kinase and PLCg. To further test this connection, we investigated whether PI 3-kinase inhibitors can abrogate the dierentiation of wild type ES cells into embryoid bodies. The results demonstrate that while the more labile wortmannin had no eect, Ly294002 added to the daily medium change, almost completely inhibited embryoid body dierentiation by the third day of culture (Figure 5a,b) . Some visceral endoderm dierentiation was, however, still visible in LY294002 treated cultures, but in signi®cantly fewer embryoid bodies than in the untreated control, and no Table 2 ). We therefore conclude that FGFR signaling through PI 3-kinase is required for normal embryoid body dierentiation.
Discussion
A dominant negative mutation of Fgfr2 was used to interfere with FGF signaling. ES cells expressing truncated Fgfr2 cDNA failed to dierentiate into the two epithelial layers of the embryoid body and no cavitation morphogenesis took place. Concomitant decrease of Akt/PKB and PLCg-1 activation in the mutant connects FGF signaling and epithelial dierentiation with the PI 3-kinase pathway. Comparing Akt/PKB and PLCg-1 activation with the activation of MAPK/Erk, the major signal transduction pathway of FGF signaling during gastrulation (Northrop et al., 1995; Umbhauer et al., 1995) , suggested that the PI 3-kinase pathway may have a special role in the early epithelial dierentiation of the embryoid body.
As it was mentioned in the introduction, due to heterodimerization among multiple FGFR isotypes, truncated FGF receptors can inhibit more than one FGFR species in the same system. We demonstrate here that ES cell derived embryoid bodies indeed express all four FGFR isotypes, and assume that the dominant negative mutation inhibited the function of more than one isotype. This was suggested by the complete inhibition of embryoid body dierentiation by the dominant negative eect, whereas ES cells homozygous for the targeted mutation of FGFR1 (Deng et al., 1994) and FGFR2 (Arman et al., 1999;  and unpublished studies) could still dierentiate both as live embryos and as ES cell derived embryoid bodies. In support of this broad eect of the dominant negative FGFR mutation is a report by Chai et al. (1998) who injected truncated Fgfr3 cDNA into fertilized mouse eggs. This treatment inhibited development after the ®fth cleavage division, in the early blastocyst stage.
Taken together, two conclusions can be drawn from the results reported here. The ®rst suggests that FGF signaling is required for embryoid body dierentiation. Secondly, the signi®cant decrease of wortmannin sensitive Akt/PKB and PLCg1 activation in the mutant, demonstrates that FGF signaling, and the epithelial morphogenesis of the embryoid body are linked to the PI 3-kinase pathway. This requirement was substantiated by the sensitivity of embryoid body dierentiation to the PI 3-kinase inhibitor Ly294002. It follows that Akt/PKB may have an important role in early epithelial dierentiation, as seen in embryoid body cultures.
Akt/PKB is one of the major anti apoptotic factors (for reviews, Datta et al., 1999; Kandel and Hay, 1999) . According to the simplest expectation, abrogation of Akt/PKB activation should have increased apoptotic cavitation in the dominant negative mutant embryoid body. This however was not the case, probably because embryoid body dierentiation was inhibited before the completion of epithelial dierentiation, that constitutes one of its inducers (Coucouvanis and Martin, 1995) .
Akt/PKB is situated at a focal point of PI 3-kinase signaling and serves multiple cellular functions (Datta et al., 1999) . Akt/PKB regulates the Forkhead family of transcription factors , to which the endoderm speci®c vHNF1 (Barbacci et al., 1999) and HNF4 (Duncan et al., 1997) genes also belong. Since they are required for visceral endoderm dierentiation, their possible connection with Akt/PKB may lead to useful insights into the role of these genes in early epithelial dierentiation. Activities of PI 3-kinase signaling, in cell to matrix and cell to cell adhesion Watton and Downward, 1999) is an additional aspect of the physiological role of this system that will have to be explored for a conclusive molecular interpretation of our ®ndings.
An important question is the relevance of these data to early embryonic development. Similarity of embryoid bodies and the egg cylinder stage rodent embryo emphasizes the probability that the PI 3-kinase-AKT/ PKB pathway may indeed be important for early (Weinkove et al., 1999) and targeted disruption of the p110 a subunit was lethal to mouse embryos at day 9.5 (Bi et al., 1999) . These data lend further support to the importance of PI 3-kinase signaling in embryonic development, nevertheless, the multiple isotypes of these genes will complicate their genetic analysis in mammals.
Materials and methods
Antibodies
For Western blotting: anti-phospho-Akt/PKB (Ser473) and anti Akt/PKB (New England Biolabs); anti-phosphotyrosine (UBI); monoclonal anti-Bovine PLCg-1 (UBI); anti-activated MAPK (Sigma); anti-MAPK (Sigma), anti-a-fetoprotein (ICN Biomedicals); anti-human FGFR1, FGFR2, FGFR3 and FGFR4 (Santa Cruz Biotechnology) were used. For immune-precipitation, polyclonal anti-Bovine phospholipase Cg-1 (UBI) was used.
Dominant-negative FGFR mutation
A fragment of FGFR2 cDNA (Raz et al., 1991) , truncated at an EcoRI site downstream of the transmembrane domain was isolated (from nucleotide 650 to nucleotide 2069) and ligated into an expression vector, controlled by the promoter of EF 1a (Mizushima and Nagata, 1990) . This was electroporated into ROSA11 ES cells (Friedrich and Soriano, 1991) together with a Hygromycine resistance (te Riele et al., 1990) gene at a molar ratio of 10 : 1 (tFGFR2: Hygromycine). Hygromycine resistant ES cell clones were screened for truncated FGFR2 by RNA blotting.
ES cells and embryoid body cultures
ES cells were cultured as described before (Arman et al., 1998) . In all experiments the ROSA11 ES cell line was used. Embryoid bodies were grown as described by Martin et al. (1977) . Brie¯y, 4610 6 undierentiated cells were seeded in 9 cm diameter tissue culture plates without feeder cells. On the second day of culture, clumps of cells were detached by pipetting with fresh ES cell medium (without LIF) and they were transferred to bacteriological petri dishes. The start of the culture period was counted from the transfer of the primary aggregates. Thereafter, the medium was changed daily till day 8 or 10. Ten mM Ly294002 (Sigma), when indicated, was added in the medium at each day.
Proliferation assay
A tritiated thymidine (methyl-3 H) incorporation assay in 24-well plates (Nunc, Denmark) was used as described before (Friedman and Glaubiger, 1982) , starting with 10 6 ES cell/ well. To ES cultures 2 mCi and to embryoid body cultures 8.5 mCi tritiated thymidine (NEN Life Science) was added 12 ± 15 h prior to harvesting and counting.
Histology and cytology
Embryoid bodies were photographed in a Zeiss SV11 stereomicroscope. For thin sections they were washed twice in PBS, ®xed for 2 h in Karnovsky's solution, post®xed in 4% paraformaldehyde and embedded in JB-4 resin (Polysciences, Inc.).
In situ hybridization
Whole mount in situ hybridization was as described (Conlon and Herrmann, 1992) with some modi®cations: after staining the embryoid bodies were quickly dehydrated and embedded in plastic for the preparation of semi-thin sections, as described above. The Fgfr1 and Fgfr2 probes have been described before (Orr-Urtreger et al., 1991) , probes for Fgfr3 and Fgfr4 were gifts from Dr C-X Deng (NIH, Bethesda, MD, USA) and have been described before (Deng et al., 1996; Weinstein et al., 1998) .
Immune-precipitation and Western blotting
Embryoid bodies were washed twice with PBS, stimulated with heparin and FGF1, and then lysed with Buer H containing 0.5% NP-40. Speci®c stimulation was by adding FGF1 (100 ng/ml), heparin (5 mg/ml), or FGF1 and heparin together at 378C for 10 min. Wortmannin (BIOMOL Research Labs) was added to the cultures at a concentration of 100 nM. The samples were centrifuged at 11 000 g and the supernatants were collected. Protein concentration was determined by the BCA reagent (Pierce). Aliquots of the extracts, normalized for protein concentration, were incubated with polyclonal antibody to PLCg-1 bound to Protein G Sepharose beads (Pharmacia Biotech) at 48C overnight.
Immunoprecipitates were washed once with ice-cold RIPA buer, twice with ice-cold 0.5 M LiCl, twice with ice-cold Buer A (Seger et al., 1994) and they were eluted in boiling Laemmli sample buer. Immune-precipitates or 100 mg samples of soluble protein were subjected to SDS ± PAGE and transferred to nitrocellulose electrophoretically. Western blotting was performed by established methods and the signal was detected by the ECL reagent (Amersham).
RT ± PCR
Total RNA was isolated from ES cells or embryoid bodies with RNAzol B (Tel-Test, Inc.). RT ± PCR was performed with the Titan RT ± PCR System (Boehringer, Mannheim, Germany). The primers for Evx-1 were 5'-TGGATGGGGG-TCAGCTTG and 5'-CGGAGCCTGG-CGTTTGC; for HNF4: 5'-TGCCCTGGACCCAGCCTAC and 5'-GGAGC-GCGTTGATGGAGGG, and for GAPDH: 5'-CAGCAAT-GCATCCTGCCACC and TGGACTGTGGTCATGAGC-CC. The density of Ethidium-Br RT ± PCR bands was measured by the NIH-Image software. Each RT ± PCR was normalized to the RT ± PCR of GAPDH performed from the same dilution. Twenty cycles were used to detect GAPDH and 25 to detect Evx-1 and HNF4 in their linear ampli®cation range. Transcript sizes: GAPDH: 98 bp; Evx-1: 410 bp; HNF4: 480 bp.
